Windtree Therapeutics, Inc. (WINT)
0.0201
0.00 (0.00%)
USD |
OTCM |
Jan 16, 16:00
Windtree Therapeutics EPS Diluted (Quarterly): -1.085 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | -1.567 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Electromed, Inc. | 0.246 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.08M |
| Total Expenses (Quarterly) | 28.08M |
| Enterprise Value | 13.41M |
| Earnings Yield | -42.34K% |
| Normalized Earnings Yield | -130197.5 |